ATE371452T1 - Neue kristalline hydrate des natriumsalzes der 3- pyridyl-1-hydroxyethyliden-1-bisphosphonsäure - Google Patents
Neue kristalline hydrate des natriumsalzes der 3- pyridyl-1-hydroxyethyliden-1-bisphosphonsäureInfo
- Publication number
- ATE371452T1 ATE371452T1 AT03757655T AT03757655T ATE371452T1 AT E371452 T1 ATE371452 T1 AT E371452T1 AT 03757655 T AT03757655 T AT 03757655T AT 03757655 T AT03757655 T AT 03757655T AT E371452 T1 ATE371452 T1 AT E371452T1
- Authority
- AT
- Austria
- Prior art keywords
- weight
- pyridyl
- sodium salt
- bisphosphonic acid
- hydroxyethylide
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000004677 hydrates Chemical class 0.000 title 1
- NOJNFULGOQGBKB-UHFFFAOYSA-M sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate Chemical compound [Na+].C1=NC(OCC)=CC=C1C(C=C1)=CC=C1CN1C2=CC=C(OCC=3N=CC(C)=CC=3)C=C2C(SC(C)(C)C)=C1CC(C)(C)C([O-])=O NOJNFULGOQGBKB-UHFFFAOYSA-M 0.000 title 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 3
- 229910052708 sodium Inorganic materials 0.000 abstract 3
- 239000011734 sodium Substances 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ20023574A CZ20023574A3 (en) | 2002-10-25 | 2002-10-25 | New crystalline form of the sodium salt of 3-pyridyl-1-hydroxyehtylidene-1,1-bisphosphonic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE371452T1 true ATE371452T1 (de) | 2007-09-15 |
Family
ID=32046706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03757655T ATE371452T1 (de) | 2002-10-25 | 2003-10-21 | Neue kristalline hydrate des natriumsalzes der 3- pyridyl-1-hydroxyethyliden-1-bisphosphonsäure |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7276604B2 (de) |
| EP (1) | EP1556041B1 (de) |
| JP (1) | JP2006511489A (de) |
| AT (1) | ATE371452T1 (de) |
| AU (1) | AU2003273728A1 (de) |
| CA (1) | CA2503154C (de) |
| CZ (1) | CZ20023574A3 (de) |
| DE (1) | DE60316010D1 (de) |
| EA (1) | EA009036B1 (de) |
| PL (1) | PL374896A1 (de) |
| SK (1) | SK50422005A3 (de) |
| UA (1) | UA83012C2 (de) |
| WO (1) | WO2004037252A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20023574A3 (en) | 2002-10-25 | 2004-04-14 | Léčiva, A.S. | New crystalline form of the sodium salt of 3-pyridyl-1-hydroxyehtylidene-1,1-bisphosphonic acid |
| WO2005066190A1 (en) * | 2004-01-02 | 2005-07-21 | Hexal A/S | New risedronate salts |
| UA83900C2 (en) * | 2004-02-26 | 2008-08-26 | ЗЕНТИВА, а.с. | Amorphous forms of risedronate monosodium |
| GB0519891D0 (en) * | 2005-09-30 | 2005-11-09 | Pliva Hrvatska D O O | Pharmaceutically acceptable salts and hydrates |
| WO2007042048A2 (en) * | 2005-10-11 | 2007-04-19 | Sandoz A/S | Method for preparing crystalline sodium risedronate |
| EP1775302A1 (de) | 2005-10-11 | 2007-04-18 | Sandoz A/S | Methode zur Herstellung von kristallinem Natriumrisedronat |
| US8076483B2 (en) | 2006-05-11 | 2011-12-13 | M/S. Ind Swift Laboratories Limited | Process for the preparation of pure risedronic acid or salts |
| GB0609465D0 (en) * | 2006-05-12 | 2006-06-21 | Pliva Hrvatska D O O | Pharmaceutically acceptable salts and polymorphic forms |
| KR100961822B1 (ko) | 2006-09-28 | 2010-06-08 | 플레밍 레보레이토리스 리미티드 | 3-피리딜-1-히드록시에틸리딘-1,1-비스포스폰산 나트륨염의순수한 다형체 제조방법 |
| GB0619891D0 (en) * | 2006-10-07 | 2006-11-15 | Pliva Istrazivanje I Razvoj D | Pharmaceutical composition of risedronate |
| KR100812528B1 (ko) | 2007-04-12 | 2008-03-12 | 보령제약 주식회사 | 리세드로네이트 나트륨염의 헤미펜타히드레이트의 선택적결정화방법 |
| WO2009003001A2 (en) * | 2007-06-27 | 2008-12-31 | Dr. Reddy's Laboratories Ltd. | Preparation of risedronate sodium hemi-pentahydrate |
| DE102007030370A1 (de) | 2007-06-29 | 2009-01-02 | Ratiopharm Gmbh | Essigsäure-Solvate von Risedronat, Polymorph hiervon, deren Herstellung und Verwendung sowie pharmazeutische Zusammensetzung, enthaltend diese |
| KR100925835B1 (ko) | 2007-12-07 | 2009-11-06 | 동우신테크 주식회사 | 리세드로네이트 나트륨 무수물 및 수화물의 제조방법 |
| CN111631686B (zh) * | 2020-05-18 | 2022-03-15 | 湖南大学 | 一种利用核磁共振成像监测胃酸pH值的胶囊及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20011061A1 (es) * | 2000-02-01 | 2001-11-20 | Procter & Gamble | Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato |
| PL372964A1 (en) * | 2002-04-11 | 2005-08-08 | Teva Pharmaceutical Indudstries, Ltd. | Novel polymorphs and pseudopolymorphs of risedronate sodium |
| CZ20023574A3 (en) | 2002-10-25 | 2004-04-14 | Léčiva, A.S. | New crystalline form of the sodium salt of 3-pyridyl-1-hydroxyehtylidene-1,1-bisphosphonic acid |
-
2002
- 2002-10-25 CZ CZ20023574A patent/CZ20023574A3/cs not_active IP Right Cessation
-
2003
- 2003-10-21 AT AT03757655T patent/ATE371452T1/de not_active IP Right Cessation
- 2003-10-21 AU AU2003273728A patent/AU2003273728A1/en not_active Abandoned
- 2003-10-21 US US10/531,877 patent/US7276604B2/en not_active Expired - Lifetime
- 2003-10-21 SK SK5042-2005A patent/SK50422005A3/sk unknown
- 2003-10-21 EP EP03757655A patent/EP1556041B1/de not_active Expired - Lifetime
- 2003-10-21 UA UAA200504948A patent/UA83012C2/ru unknown
- 2003-10-21 WO PCT/CZ2003/000056 patent/WO2004037252A1/en active IP Right Grant
- 2003-10-21 CA CA002503154A patent/CA2503154C/en not_active Expired - Fee Related
- 2003-10-21 JP JP2004545690A patent/JP2006511489A/ja active Pending
- 2003-10-21 PL PL03374896A patent/PL374896A1/xx unknown
- 2003-10-21 EA EA200500701A patent/EA009036B1/ru not_active IP Right Cessation
- 2003-10-21 DE DE60316010T patent/DE60316010D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| SK50422005A3 (sk) | 2005-08-04 |
| WO2004037252A1 (en) | 2004-05-06 |
| EA009036B1 (ru) | 2007-10-26 |
| CZ293349B6 (cs) | 2004-04-14 |
| JP2006511489A (ja) | 2006-04-06 |
| EP1556041A1 (de) | 2005-07-27 |
| US20060148762A1 (en) | 2006-07-06 |
| CZ20023574A3 (en) | 2004-04-14 |
| DE60316010D1 (de) | 2007-10-11 |
| CA2503154C (en) | 2009-09-15 |
| AU2003273728A1 (en) | 2004-05-13 |
| UA83012C2 (ru) | 2008-06-10 |
| US7276604B2 (en) | 2007-10-02 |
| CA2503154A1 (en) | 2004-05-06 |
| EP1556041B1 (de) | 2007-08-29 |
| PL374896A1 (en) | 2005-11-14 |
| EA200500701A1 (ru) | 2006-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE371452T1 (de) | Neue kristalline hydrate des natriumsalzes der 3- pyridyl-1-hydroxyethyliden-1-bisphosphonsäure | |
| BRPI0408369A (pt) | derivados de indol úteis para o tratamento de doenças | |
| NO20052493L (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger. | |
| NO20012158L (no) | Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav | |
| MXPA04001037A (es) | Derivados de n-fenilpirrol guanidina como ligandos del receptor de melanocortina. | |
| CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
| MY135841A (en) | Novel benzodioxoles | |
| SE0100172D0 (sv) | New inhibitors against galectins | |
| DE60236256D1 (de) | Magnesium-substituierte hydroxylapatite | |
| NO20050134L (no) | Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse | |
| SE0201635D0 (sv) | Novel compounds | |
| EA200100184A1 (ru) | Новые гидратные формы алендроната натрия, способы их получения и фармацевтические композиции | |
| BR0212101A (pt) | 7-aza [2.2.1] biciclo-heptanos substituìdos com heteroarila para o tratamento de doenças | |
| ATE400270T1 (de) | Pharmazeutische zusammensetzungen mit sertaconazol für vaginale verwendung | |
| ATE406903T1 (de) | Zusammensetzung und ihre verwendungszwecke zur bekämpfung von kater | |
| NO20034236L (no) | Ny fremgangsmate for den industrielle syntese av tetraestere av 5-[bis(karboksymetyl)amino]-3-karboksymetyl-4-cyano-2-tiofenkarboksylsyre, og anvendelse i syntesen av bivalente salter av ranelinsyre og deres hydrater | |
| TW200627095A (en) | Remover composition | |
| NO20044571L (no) | Isokinolinderivater | |
| NO20045063L (no) | Preparater inneholdende minst ett diformat | |
| NO924416L (no) | Vannfri, flytende vaskemiddelblanding | |
| BRPI0410758A (pt) | composições, dispositivos e métodos para estabilizar o dióxido de halogênio e aumentar sua eficácia | |
| ATE464043T1 (de) | Pharmazeutische zusammensetzung enthaltend l- arginin | |
| HUP0301864A2 (hu) | Fenoláttartalmú, alacsony fagyáspontú készítmény | |
| EA200401090A1 (ru) | Композиция на основе диклофенака для местного лечения заболеваний орофарингеальной полости | |
| BRPI0415853B8 (pt) | processo para preparar um sal de cloridrato de telavancina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |